Basic Information
| RNALocate ID: | RLID:11000887 |
| RNA Symbol: | hsa-miR-28-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-28-5p |
| RNA ID: | miRBase:MIMAT0000085 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001367 | Cytoplasm | Neural progenitor cells | 21363885 |
| RLID:01001368 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001369 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001370 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11000885 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000886 | Exosome | Brain tissue | 23382797 |
| RLID:11000888 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000021 | Exosome | Seminal fluid | |
| RLID-D:11000284 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-28-5p | Splenic marginal zone lymphoma | MNDR-E-MI-34064 |
| MNDR | hsa-miR-28-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-34065 |
| MNDR | hsa-miR-28-5p | Glomerulosclerosis | MNDR-E-MI-34066 |
| MNDR | hsa-miR-28-5p | Oral squamous cell carcinoma | MNDR-E-MI-34067 |
| MNDR | hsa-miR-28-5p | Medulloblastoma | MNDR-E-MI-34068 |
| MNDR | hsa-miR-28-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-34069 |
| MNDR | hsa-miR-28-5p | Lymphoma | MNDR-E-MI-34070 |
| MNDR | hsa-miR-28-5p | Lymphoma non-hodgkin | MNDR-E-MI-34071 |
| MNDR | hsa-miR-28-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-34072 |
| MNDR | hsa-miR-28-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-34073 |
| MNDR | hsa-miR-28-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-34074 |
| MNDR | hsa-miR-28-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-34075 |
| MNDR | hsa-miR-28-5p | Her2-receptor positive breast cancer | MNDR-E-MI-34076 |
| MNDR | hsa-miR-28-5p | Breast cancer luminal | MNDR-E-MI-34077 |
| MNDR | hsa-miR-28-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-34078 |
| MNDR | hsa-miR-28-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-34079 |
| MNDR | hsa-miR-28-5p | Prostate cancer | MNDR-E-MI-34080 |
| MNDR | hsa-miR-28-5p | Gastric cancer | MNDR-E-MI-34081 |
| MNDR | hsa-mir-28-5p | Gastric cancer | MNDR-E-MI-34082 |
| MNDR | hsa-miR-28-5p | Gastric lymphoma | MNDR-E-MI-34083 |
| MNDR | hsa-miR-28-5p | Alzheimer disease | MNDR-E-MI-34084 |
| MNDR | hsa-miR-28-5p | Intracranial aneurysm | MNDR-E-MI-34085 |
| MNDR | hsa-miR-28-5p | Bladder cancer | MNDR-E-MI-34086 |
| MNDR | hsa-miR-28-5p | Esophageal carcinoma | MNDR-E-MI-34087 |
| MNDR | hsa-miR-28-5p | Dysautonomia familial | MNDR-E-MI-34088 |
| MNDR | hsa-miR-28-5p | Leukemia | MNDR-E-MI-34089 |
| MNDR | hsa-miR-28-5p | Huntington disease | MNDR-E-MI-34090 |
| MNDR | hsa-miR-28-5p | Chorea | MNDR-E-MI-34091 |
| MNDR | hsa-miR-28-5p | Cardiovascular disease | MNDR-E-MI-34092 |
| MNDR | hsa-miR-28-5p | Carotid stenosis | MNDR-E-MI-34093 |
| MNDR | hsa-miR-28-5p | Down syndrome | MNDR-E-MI-34094 |
| MNDR | hsa-miR-28-5p | Parkinson disease | MNDR-E-MI-34095 |
| MNDR | hsa-miR-28-5p | Basal-like breast cancer | MNDR-E-MI-34096 |
| MNDR | hsa-miR-28-5p | Neuroendocrine neoplasia | MNDR-E-MI-34097 |
| MNDR | hsa-miR-28-5p | Pancreatic cancer | MNDR-E-MI-34098 |
| MNDR | hsa-miR-28-5p | Melanoma | MNDR-E-MI-34099 |
| MNDR | hsa-miR-28-5p | Rectum adenocarcinoma | MNDR-E-MI-34100 |
| MNDR | hsa-miR-28-5p | Nephroblastoma | MNDR-E-MI-34101 |
| MNDR | hsa-miR-28-5p | Colon cancer | MNDR-E-MI-34102 |
| MNDR | hsa-miR-28-5p | Myeloproliferative neoplasm | MNDR-E-MI-34103 |
| MNDR | hsa-miR-28-5p | Colon adenocarcinoma | MNDR-E-MI-34104 |
| MNDR | hsa-miR-28-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-34105 |
| MNDR | hsa-mir-28-5p | Ovarian cancer | MNDR-E-MI-34106 |
| MNDR | hsa-miR-28-5p | Prostate adenocarcinoma | MNDR-E-MI-34107 |
| MNDR | hsa-miR-28-5p | Carcinoma ductal breast | MNDR-E-MI-34108 |
| MNDR | hsa-miR-28-5p | Glioblastoma | MNDR-E-MI-34109 |
| MNDR | hsa-miR-28-5p | Glioma | MNDR-E-MI-34110 |
| MNDR | hsa-miR-28-5p | Chordoma | MNDR-E-MI-34111 |
| MNDR | hsa-miR-28-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-34112 |
| MNDR | hsa-miR-28-5p | Osteosarcoma | MNDR-E-MI-34113 |
| MNDR | hsa-miR-28-5p | Inclusion body myositis | MNDR-E-MI-34114 |
| MNDR | hsa-miR-28-5p | Middle cerebral artery infarction | MNDR-E-MI-34115 |
| MNDR | hsa-miR-28-5p | Cervical adenocarcinoma | MNDR-E-MI-34116 |
| MNDR | hsa-miR-28-5p | Gastric adenocarcinoma | MNDR-E-MI-34117 |
| MNDR | hsa-miR-28-5p | Cervical squamous cell carcinoma | MNDR-E-MI-34118 |
| MNDR | hsa-miR-28-5p | Bone-invasive pituitary adenoma | MNDR-E-MI-34119 |
| MNDR | hsa-miR-28-5p | Lung squamous cell carcinoma | MNDR-E-MI-34120 |
| MNDR | hsa-miR-28-5p | Lung adenocarcinoma | MNDR-E-MI-34121 |
| MNDR | hsa-miR-28-5p | Adrenocortical carcinoma | MNDR-E-MI-34122 |
| MNDR | hsa-miR-28-5p | Thyroid carcinoma | MNDR-E-MI-34123 |
| MNDR | hsa-miR-28-5p | Bladder urothelial carcinoma | MNDR-E-MI-34124 |
| MNDR | hsa-miR-28-5p | Pancreatic adenocarcinoma | MNDR-E-MI-34125 |
| MNDR | hsa-miR-28-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-34126 |
| MNDR | hsa-miR-28-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-34127 |
| MNDR | hsa-miR-28-5p | Clear cell renal cell carcinoma | MNDR-E-MI-34128 |
| MNDR | hsa-miR-28-5p | Cholangiocarcinoma | MNDR-E-MI-34129 |
| MNDR | hsa-miR-28-5p | Esophageal cancer | MNDR-E-MI-34130 |
| MNDR | hsa-miR-28-5p | Synovial sarcoma | MNDR-E-MI-34131 |
| MNDR | hsa-miR-28-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-34132 |
| MNDR | hsa-miR-28-5p | T acute lymphoblastic leukemia | MNDR-E-MI-34133 |
| MNDR | hsa-miR-28-5p | Acute t cell leukemia | MNDR-E-MI-34134 |
| MNDR | hsa-miR-28-5p | Adenoma | MNDR-E-MI-34135 |
| MNDR | hsa-miR-28-5p | Breast invasive carcinoma | MNDR-E-MI-34136 |
| MNDR | hsa-miR-28-5p | Hepatocellular carcinoma | MNDR-E-MI-34137 |
| MNDR | hsa-miR-28-5p | B-cell lymphoma | MNDR-E-MI-34138 |
| MNDR | hsa-miR-28-5p | Rheumatoid arthritis | MNDR-E-MI-34139 |
| MNDR | hsa-miR-28-5p | T-cell leukemia | MNDR-E-MI-34140 |
| MNDR | hsa-miR-28-5p | Hodgkin lymphoma | MNDR-E-MI-34141 |
| MNDR | hsa-miR-28-5p | Burkitt lymphoma | MNDR-E-MI-34142 |
| MNDR | hsa-miR-28-5p | Neuromyelitis optica | MNDR-E-MI-34143 |
| MNDR | hsa-miR-28-5p | Skin cutaneous melanoma | MNDR-E-MI-34144 |
| MNDR | hsa-miR-28-5p | Skin melanoma | MNDR-E-MI-34145 |
| MNDR | hsa-miR-28-5p | Colorectal cancer | MNDR-E-MI-34146 |
| MNDR | hsa-miR-28-5p | Nasopharynx carcinoma | MNDR-E-MI-34147 |
| MNDR | hsa-miR-28-5p | Multiple myeloma | MNDR-E-MI-34148 |
| MNDR | hsa-miR-28-5p | Acute lymphocytic leukemia | MNDR-E-MI-34149 |
| MNDR | hsa-miR-28-5p | Uterine cervical neoplasms | MNDR-E-MI-34150 |
| MNDR | hsa-miR-28-5p | Nasopharyngeal cancer | MNDR-E-MI-34151 |
| MNDR | hsa-miR-28-5p | Prostatic neoplasms | MNDR-E-MI-34152 |
| MNDR | hsa-miR-28-5p | Epstein-barr virus infections | MNDR-E-MI-34153 |
| MNDR | hsa-miR-28-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-34154 |
| MNDR | hsa-miR-28-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-34155 |
| MNDR | hsa-miR-28-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-34156 |
| MNDR | hsa-miR-28-5p | Duke C | MNDR-E-MI-34157 |
| MNDR | hsa-miR-28-5p | Tubulovillous adenoma | MNDR-E-MI-34158 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | BAG1 | Homo sapiens | RR00209812 |
TOP